Skip to content

Verification of the effect of ultra-high hydrostatic pressurizing brown rice on physiological functions in the elderly

Elucidation of the effects of ultra-high hydrostatic pressurizing brown rice on physiological functions in the elderly - Analysis of the effects of ultra-high hydrostatic pressurizing brown rice on human physiological functions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053587
Enrollment
52
Registered
2024-02-09
Start date
2015-09-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy elderly

Interventions

Individuals who consume 12-24 months of ultra-high hydrostatic press brown rice Individuals who consume 12-24 months of white rice

Sponsors

Shimane university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Between 65 and 85 years of age at the baseline. (2) Cognitive function test scores at the baseline must meet the following criteria 1) MMSE total score of 22 points or more 2) HDS-R score of 21 or more (3) Have obtained written consent from the subject to participate in the study. (4) Possible to converse in Japanese.

Exclusion criteria

Exclusion criteria: Volunteers with any medical illness, including cardiac, renal, hepatic, respiratory disease, diabetes mellitus, or osteoporosis, with metabolic, endocrine, or hematological diseases, those eating brown rice daily, consuming supplements to treat bone diseases or to prevent osteoporosis and/or improve cognitive and mental function that could influence the results of the study, and smokers and those with allergies and hypersensitivity were excluded.

Design outcomes

Primary

MeasureTime frame
Cognitive and emotional function, bone mineral density, blood pressure, blood biochemical tests, bone metabolism markers, blood monoamine levels, and body composition will be evaluated at 12 and 24 months after the start of treatment.

Countries

Japan

Contacts

Public ContactKentaro Matsuzaki

Shimane university Faculty of Medicine

matuzaki@med.shimane-u.ac.jp0853202114

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026